PTAB Holds Technical Difficulties Will Not Save Late-Filed IPR Petitions

13 June 2016 PTAB Trial Insights Blog


The PTAB recently stood firm in denying a petitioner’s motion to change the filing dates of two IPR petitions that missed a statutory deadline by less than ten minutes. Case IPR2016-00281 and IPR2016-00282 (Patents 8,603,514 B2 and 8,017,150 B2). The petitioner, Teva Pharmaceuticals USA, Inc., was facing a 1-year statutory IPR filing deadline of December 3, 2015, set by a complaint alleging patent infringement served on Teva a year earlier.

A legal assistant handling the IPR filings started filing the IPR petitions at 11:11 pm on December 3, 2015, after facing technical difficulties with an unrelated petition that the legal assistant filed first that evening. The technical difficulties continued while the legal assistant was filing the Teva petitions. These technical difficulties included slow processing, frozen screens, and rejected payments. The USPTO Patent Review Processing System (“PRPS”) eventually issued filing notifications for the two IPR petitions at 12:01 AM and 12:09 AM on December 4, one day after the statutory deadline.

The Board noted two major considerations that hurt Teva’s case. First, under the relevant rule a petition is given a filing date upon completing two additional requirements besides timely filing the petition. The petition must also be served on the patent owner and the applicable fee must be paid. 37 CFR 42.106(a). Neither of the two additional requirements were met before the clock struck 12 midnight on December 3. The Board was not swayed by several decisions Teva had cited supporting its motion to change the filing date, because none of those decisions involved a failure to satisfy all three requirements of 37 CFR 42.106(a).

Second, the Board noted that Teva had not provided objective evidence, such as screen shots or descriptions of error messages, that the technical difficulties were solely do to the PRPS and not due to problems unrelated to PRPS. Indeed, some evidence showed technical problems arising from Teva’s use of an invalid credit card account and a deposit account with insufficient funds.

This decision highlights the need to avoid last-day filings because the Board may not be readily persuaded to show mercy to the late-filer. In distinguishing earlier decisions sympathetic to the late-filing petitioner, the Board noted that the decisions were non-precedential, suggesting that the Board would retain its discretion to grant or deny motions on more similar facts. The Board also commented on Teva’s lack of explanation for why the petitioner started filing the petitions so close to the deadline, although the Board gave no indication as to what sorts of reasons might have been persuasive.

It would probably also be a good idea to instruct personnel working on last-day filings to make a record of all error messages and technical problems. Finally, once it became clear that it was possible the deadline could be missed, Teva could have put itself in a better position by minimizing the number of omissions, e.g., by paying the petition fee and serving the petition on the patent owner before filing the petition.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.

Related Services


Episode 3: The Future Powered By Hyperscale Cloud Computing with David Sloan of Microsoft
06 December 2022
Innovative Technology Insights
2023 M&A Outlook
05 December 2022
Foley Ignite
COVID-related Form I-9 Remote Verification Flexibilities Extended Through July 31, 2023
05 December 2022
Labor & Employment Law Perspectives
Learnings from Recent Physician Practice Private Equity Transactions
05 December 2022
Health Care Law Today
What You Should Know About Payor/Provider Convergence
25-26 January 2023
Los Angeles, CA
ATA EDGE2022 Policy Conference | American Telemedicine Association
7-9 December 2022
Washington, D.C.
CLE Weeks
5-16 December 2022
Milwaukee, WI
Foley Sponsors Ernst & Young Entrepreneur of the Year® Program
1 December 2021 - 30 November 2022
Michigan and Northwest Ohio Region